New patent for Amneal drug LYVISPAH

Annual Drug Patent Expirations for LYVISPAH Lyvispah is a drug marketed by Amneal and is included in one NDA. It is available from two suppliers. There are four patents protecting…

Source

Biotechblog
Scroll to Top